0,825  0,004  Metabolic disease treatment
0,811  0,005  Antiobesity
0,804  0,002  Postmenopausal disorders treatment
0,805  0,004  Hepatic disorders treatment
0,783  0,004  Cardiovascular analeptic
0,781  0,018  Antiinflammatory
0,696  0,014  Antidiabetic
0,696  0,014  Cyclophilin D inhibitor
0,681  0,003  Antieczematic
0,635  0,008  Lipoprotein disorders treatment
0,617  0,005  Sedative
0,607  0,005  Hair growth stimulant
0,639  0,041  Apoptosis agonist
0,605  0,030  Transcription factor NF kappa B inhibitor
0,585  0,010  Nitric oxide antagonist
0,557  0,004  Antiviral (Influenza)
0,543  0,015  Apoptosis antagonist
0,538  0,020  Sensitization
0,516  0,005  Antiacne
0,534  0,024  Immunosuppressant
0,539  0,031  Antibacterial
0,536  0,046  Antineoplastic (breast cancer)
0,471  0,004  Antifungal enhancer
0,471  0,005  Sepsis treatment
0,493  0,029  Respiratory analeptic
0,470  0,007  Antieczematic atopic
0,495  0,035  Antipruritic, allergic
0,514  0,054  Caspase 9 stimulant
0,466  0,008  Contraceptive
0,461  0,004  Aromatase inhibitor
0,460  0,005  Lipocortins synthesis antagonist
0,450  0,029  AR expression inhibitor
0,421  0,013  Abortion inducer
0,453  0,049  Antileukemic
0,388  0,008  Antiviral (Influenza A)
0,412  0,035  Analeptic
0,396  0,025  Antiparasitic
0,403  0,038  NOS3 expression inhibitor
0,395  0,039  Cardioprotectant
0,413  0,062  Antineoplastic (lung cancer)
0,370  0,019  UGT1A4 substrate
0,370  0,020  Antihelmintic
0,364  0,016  UGT2B7 substrate
0,355  0,015  Antipruritic, non-allergic
0,382  0,043  Antineoplastic (pancreatic cancer)
0,374  0,037  UGT2B4 substrate
0,365  0,031  Sodium/bile acid cotransporter inhibitor
0,365  0,031  Antineoplastic (osteosarcoma)
0,381  0,047  Antipsoriatic
0,343  0,011  Diabetic nephropathy treatment
0,404  0,076  TNF expression inhibitor
0,375  0,049  Antihypercholesterolemic
0,334  0,007  UGT2B9 substrate
0,368  0,044  CTGF expression inhibitor
0,359  0,044  Calcium channel activator
0,367  0,058  Cholesterol antagonist
0,321  0,017  Prostate disorders treatment
0,313  0,026  Hepatoprotectant
0,345  0,062  Antifungal
0,285  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,295  0,021  Interferon gamma antagonist
0,298  0,024  Pneumotoxic
0,350  0,078  CYP3A4 substrate
0,291  0,025  Antiviral (Herpes)
0,327  0,064  Antineoplastic (ovarian cancer)
0,303  0,042  Chemopreventive
0,283  0,023  Neurotrophic factor enhancer
0,283  0,024  Antiviral (Hepatitis)
0,271  0,022  UGT2B15 substrate
0,293  0,046  DNA synthesis inhibitor
0,306  0,060  Antidiabetic (type 2)
0,309  0,064  Antineoplastic (endocrine cancer)
0,253  0,008  Contraceptive female
0,285  0,041  Antiparkinsonian, rigidity relieving
0,303  0,059  Antihypoxic
0,321  0,077  ICAM1 expression inhibitor
0,276  0,038  UGT1A1 substrate
0,255  0,025  Protein kinase stimulant
0,237  0,009  Arachidonic acid antagonist
0,309  0,082  Prostate cancer treatment
0,255  0,033  Prostatic (benign) hyperplasia treatment
0,227  0,016  Antirickettsial
0,257  0,047  UDP-glucuronosyltransferase substrate
0,236  0,031  Melanin inhibitor
0,208  0,013  Androgen antagonist
0,225  0,030  Antiviral (Hepatitis C)
0,253  0,058  Dependence treatment
0,261  0,068  Antiprotozoal (Leishmania)
0,203  0,011  Contraceptive male
0,206  0,016  Choleretic
0,220  0,031  Interleukin 6 antagonist
0,219  0,032  Toxic, respiratory center
0,195  0,010  Actinic keratosis treatment
0,203  0,020  Endometrios treatment
0,259  0,077  Chemoprotective
0,242  0,061  Antihypotensive
0,204  0,027  DNA polymerase I inhibitor
0,233  0,058  Antialcoholic
0,261  0,088  Antineoplastic (melanoma)
0,200  0,027  Cholesterol synthesis inhibitor
0,188  0,015  Antispirochetal
0,193  0,021  Microtubule formation inhibitor
0,223  0,052  Insulin sensitizer
0,188  0,017  Antineoplastic alkaloid
0,175  0,008  UGT2B11 substrate
0,175  0,008  Anabolic
0,175  0,009  SULT1E1 substrate
0,226  0,062  VCAM1 expression inhibitor
0,247  0,086  Antioxidant
0,172  0,012  Ca2+-transporting ATPase inhibitor
0,214  0,056  P-glycoprotein inhibitor
0,197  0,040  UGT2B10 substrate
0,200  0,044  Phospholipase C inhibitor
0,247  0,094  CYP2C19 substrate
0,180  0,028  Antismoking
0,251  0,098  Antiepileptic
0,176  0,025  Antineoplastic antibiotic
0,295  0,145  Analgesic
0,236  0,087  Proliferative diseases treatment
0,276  0,126  CYP2C9 substrate
0,231  0,082  NOS2 expression inhibitor
0,187  0,044  Anesthetic
0,149  0,011  Antiprotozoal activity enhancer
0,169  0,033  Autism spectrum disorders treatment
0,243  0,108  GST M1-1 substrate
0,142  0,008  Androgen agonist
0,230  0,096  UGT1A9 substrate
0,232  0,101  5 Hydroxytryptamine uptake stimulant
0,181  0,050  Antiparkinsonian, tremor relieving
0,137  0,007  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,168  0,038  Antifungal (Cryptococcus)
0,223  0,095  Antineoplastic (sarcoma)
0,244  0,118  Bone diseases treatment
0,240  0,116  Antimycobacterial
0,158  0,036  Growth stimulant
0,199  0,079  Cytotoxic
0,205  0,089  UGT1A6 substrate
0,157  0,044  Antihyperlipoproteinemic
0,133  0,023  Antibiotic
0,120  0,011  Ca(v)3.1 blocker
0,225  0,117  Antineoplastic (colorectal cancer)
0,198  0,090  Antiulcerative
0,202  0,096  RNA-directed DNA polymerase inhibitor
0,114  0,009  Antimycoplasmal
0,108  0,006  SULT2A1 substrate
0,105  0,005  Postcoital contraceptive
0,118  0,018  Na+ K+ transporting ATPase inhibitor
0,115  0,016  T cell inhibitor
0,133  0,034  Estrogen antagonist
0,199  0,100  Peptidyltransferase inhibitor
0,179  0,081  Carcinogenic
0,212  0,116  Antineoplastic (colon cancer)
0,121  0,025  Antiviral (Trachoma)
0,103  0,008  Aldosterone antagonist
0,149  0,054  Cocaine dependence treatment
0,149  0,054  Pregnane X receptor agonist
0,108  0,014  Anticholelithogenic
0,185  0,094  Antihypertriglyceridemic
0,157  0,068  Acaricide
0,150  0,062  Adenylate cyclase stimulant
0,102  0,014  Antitreponemal
0,106  0,020  Narcotic antagonist
0,163  0,077  Sigma receptor agonist
0,092  0,008  Lipocortins synthesis agonist
0,145  0,061  Psychosexual dysfunction treatment
0,174  0,091  Anesthetic general
0,212  0,130  Gastrin inhibitor
0,095  0,014  Protein 50S ribosomal subunit inhibitor
0,086  0,007  RNA-directed RNA polymerase stimulant
0,083  0,005  Pregnane X receptor antagonist
0,229  0,153  FMO1 substrate
0,126  0,051  SULT1A1 substrate
0,083  0,010  Progesterone antagonist
0,118  0,051  GABA C receptor agonist
0,081  0,013  Purinergic P2X antagonist
0,111  0,045  Prolactin inhibitor
0,098  0,034  Glycine receptor antagonist
0,194  0,132  Antiosteoporotic
0,070  0,008  Glucocorticoid antagonist
0,091  0,029  Premenstrual syndrome treatment
0,093  0,032  Estrogen receptor alpha antagonist
0,083  0,022  Estrogen agonist
0,111  0,052  Sulfotransferase substrate
0,108  0,050  Estrogen receptor beta antagonist
0,180  0,122  Cytostatic
0,105  0,048  Posttraumatic stress disorder treatment
0,085  0,029  Purinergic P2 antagonist
0,086  0,032  Glycine receptor agonist
0,106  0,052  Antineoplastic, alkylator
0,197  0,145  CYP2D6 substrate
0,066  0,015  Sodium/calcium exchanger inhibitor
0,098  0,047  Ornithine decarboxylase inhibitor
0,125  0,075  Vanilloid 1 agonist
0,163  0,114  Teratogen
0,091  0,044  Opioid kappa receptor antagonist
0,149  0,103  ATPase inhibitor
0,169  0,125  Antineoplastic (cervical cancer)
0,106  0,063  UGT2B1 substrate
0,072  0,029  Hypercalcemia treatment
0,058  0,016  5-Alpha-reductase inhibitor
0,136  0,095  UGT1A3 substrate
0,045  0,005  Progesterone agonist
0,053  0,013  GABA uptake inhibitor
0,061  0,022  Anesthetic inhalation
0,041  0,004  Hedgehog signaling activator
0,115  0,079  Antiviral (Influenza B)
0,046  0,010  Tubulin agonist
0,080  0,048  Analgesic, opioid
0,042  0,010  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,128  0,097  Diuretic
0,070  0,039  Glutamate (mGluR6) antagonist
0,054  0,023  Microtubule stabilization
0,064  0,036  Heme oxygenase stimulant
0,050  0,023  Premature ejaculation treatment
0,054  0,027  HCV NS3/NS4A protease inhibitor
0,089  0,064  Paget's disease treatment
0,030  0,005  Progesterone receptor B antagonist
0,146  0,122  Embryotoxic
0,045  0,023  Hypogonadism treatment
0,109  0,088  Alcohol dehydrogenase substrate
0,099  0,079  Mucolytic
0,028  0,008  Corticosteroid-like
0,043  0,023  Membrane dipeptidase inhibitor
0,049  0,032  Mineralocorticoid receptor antagonist
0,202  0,184  GST A substrate
0,069  0,052  Prokinetic
0,045  0,028  Opioid kappa receptor agonist
0,165  0,149  Spasmolytic
0,038  0,022  Estrogen receptor alpha agonist
0,082  0,066  Opioid antagonist
0,081  0,067  Transcription factor NF kappa B stimulant
0,092  0,077  Topoisomerase I inhibitor
0,021  0,007  Telomerase stimulant
0,097  0,084  Antihypermotility
0,052  0,039  Nicotinic alpha3beta2 receptor antagonist
0,047  0,034  Cholesterol esterase inhibitor
0,032  0,022  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,023  0,014  Estrone sulfatase inhibitor
0,103  0,094  Mental retardation treatment
0,027  0,018  Nicotinic acid receptor 2 antagonist
0,032  0,024  Glutamate (mGluR3) agonist
0,121  0,113  CC chemokine 6 receptor antagonist
0,036  0,029  Glucose-6-phosphate dehydrogenase inhibitor
0,016  0,009  Antibiotic Tetracycline-like
0,022  0,015  Vitamin D receptor antagonist
0,015  0,009  Glucocorticoid agonist
0,081  0,075  Antidote, mercury
0,010  0,006  Progesterone receptor A antagonist
0,043  0,038  Parathyroid hormone antagonist
0,019  0,015  Retinoic acid alpha receptor antagonist
0,015  0,011  NMDA receptor phencyclidine site antagonist
0,007  0,003  Transcortin receptor antagonist
0,095  0,093  Antitussive
0,089  0,087  HDL-cholesterol increasing
0,098  0,097  Menstruation disorders treatment
0,040  0,039  Alpha 1L adrenoreceptor agonist

